Ausgabe 1/2020
Inhalt (12 Artikel)
Editorial
HTA for pharmaceuticals in Europe: will the mountain deliver a mouse?
Livio Garattini, Anna Padula
Open Access
Original Paper
Cost–consequence analysis of fluticasone furoate/vilanterol for asthma management in Spain: an analysis based on the Salford Lung Study in asthma
Laura Amanda Vallejo-Aparicio, Jesús Molina, Iñigo Ojanguren, Ana Viejo Casas, Alicia Huerta, Henrik Svedsater
Original Paper
The income gradient and child mental health in Australia: does it vary by assessors?
Rasheda Khanam, Son Nghiem, Maisha Rahman
Original Paper
Speeding up the clinical pathways by accessing emergency departments
Rosella Levaggi, Marcello Montefiori, Luca Persico
Original Paper
The value of persistence in treatment with subcutaneous TNF-alpha inhibitors for ankylosing spondylitis
Axel Svedbom, Johan Dalén, Moa Ivergård, Rebekah H. Borse, Christopher M. Black, Karin Luttropp, Sumesh Kachroo
Original Paper
Provision of health care services and regional diversity in Germany: insights from a Bayesian health frontier analysis with spatial dependencies
Rouven Edgar Haschka, Katharina Schley, Helmut Herwartz
Original Paper
A cost-utility analysis of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction
Svenn Alexander Hansen, Eline Aas, Oddvar Solli
Open Access
Original Paper
Inefficiencies in a healthcare system with a regulatory split of power: a spatial panel data analysis of avoidable hospitalisations in Austria
Anna-Theresa Renner
Open Access
Original Paper
Global budget versus cost ceiling: a natural experiment in hospital payment reform in the Netherlands
Katalin Gaspar, France Portrait, Eric van der Hijden, Xander Koolman
Original Paper
Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study
Yuliya Chuvarayan, Robert P. Finger, Juliane Köberlein-Neu
Open Access
Original Paper
Does external reference pricing deliver what it promises? Evidence on its impact at national level
Panos Kanavos, Anna-Maria Fontrier, Jennifer Gill, Olina Efthymiadou
Open Access
Original Paper
Cost-effectiveness analysis of the first-line EGFR-TKIs in patients with non-small cell lung cancer harbouring EGFR mutations
Marscha S. Holleman, Maiwenn J. Al, Remziye Zaim, Harry J. M. Groen, Carin A. Uyl-de Groot